Pharmaniaga Bhd (7081) - Total Assets
Based on the latest financial reports, Pharmaniaga Bhd (7081) holds total assets worth RM2.36 Billion MYR (≈ $591.86 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore 7081 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Pharmaniaga Bhd - Total Assets Trend (2012–2025)
This chart illustrates how Pharmaniaga Bhd's total assets have evolved over time, based on quarterly financial data. See 7081 net asset value for net asset value and shareholders' equity analysis.
Pharmaniaga Bhd - Asset Composition Analysis
Current Asset Composition (December 2025)
Pharmaniaga Bhd's total assets of RM2.36 Billion consist of 65.2% current assets and 34.8% non-current assets.
| Asset Category | Amount (MYR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RM0.00 | 4.9% |
| Accounts Receivable | RM446.69 Million | 19.9% |
| Inventory | RM729.82 Million | 32.5% |
| Property, Plant & Equipment | RM602.78 Million | 26.8% |
| Intangible Assets | RM74.62 Million | 3.3% |
| Goodwill | RM77.03 Million | 3.4% |
Asset Composition Trend (2012–2025)
This chart illustrates how Pharmaniaga Bhd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Pharmaniaga Bhd (7081) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Pharmaniaga Bhd's current assets represent 65.2% of total assets in 2025, an increase from 59.1% in 2012.
- Cash Position: Cash and equivalents constituted 4.9% of total assets in 2025, up from 2.9% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, unchanged from 6.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 32.5% of total assets.
Pharmaniaga Bhd Competitors by Total Assets
Key competitors of Pharmaniaga Bhd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Selcuk Ecza Deposu Ticaret ve Sanayi AS
IS:SELEC
|
Turkey | TL80.93 Billion |
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$46.10 Million |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥235.37 Billion |
Pharmaniaga Bhd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.92 | 0.65 | 0.93 |
| Quick Ratio | 0.53 | 0.37 | 0.44 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | RM-140.86 Million | RM-746.65 Million | RM-140.72 Million |
Pharmaniaga Bhd - Advanced Valuation Insights
This section examines the relationship between Pharmaniaga Bhd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.53 |
| Latest Market Cap to Assets Ratio | 0.19 |
| Asset Growth Rate (YoY) | 12.8% |
| Total Assets | RM2.25 Billion |
| Market Capitalization | $421.44 Million USD |
Valuation Analysis
Below Book Valuation: The market values Pharmaniaga Bhd's assets below their book value (0.19x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Pharmaniaga Bhd's assets grew by 12.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Pharmaniaga Bhd (2012–2025)
The table below shows the annual total assets of Pharmaniaga Bhd from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | RM2.25 Billion ≈ $564.10 Million |
+12.78% |
| 2024-12-31 | RM1.99 Billion ≈ $500.20 Million |
+4.04% |
| 2023-12-31 | RM1.91 Billion ≈ $480.76 Million |
+3.66% |
| 2022-12-31 | RM1.85 Billion ≈ $463.79 Million |
-18.18% |
| 2021-12-31 | RM2.26 Billion ≈ $566.87 Million |
+42.89% |
| 2020-12-31 | RM1.58 Billion ≈ $396.73 Million |
-0.76% |
| 2019-12-31 | RM1.59 Billion ≈ $399.77 Million |
-16.53% |
| 2018-12-31 | RM1.91 Billion ≈ $478.97 Million |
+18.66% |
| 2017-12-31 | RM1.61 Billion ≈ $403.65 Million |
-4.48% |
| 2016-12-31 | RM1.68 Billion ≈ $422.57 Million |
+12.51% |
| 2015-12-31 | RM1.50 Billion ≈ $375.60 Million |
+20.35% |
| 2014-12-31 | RM1.24 Billion ≈ $312.08 Million |
+11.88% |
| 2013-12-31 | RM1.11 Billion ≈ $278.94 Million |
-9.16% |
| 2012-12-31 | RM1.22 Billion ≈ $307.05 Million |
-- |
About Pharmaniaga Bhd
Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines… Read more